Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer

Tumor-Infiltrating Lymphocytes in Breast Cancer: Ready for Prime Time?

(2015) Alberto Ocaña et al.   JOURNAL OF CLINICAL ONCOLOGY

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome

(2015) Yi Huang et al.   Oncotarget

Correction: The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis

(2015)   PLoS One

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers

(2015) Roberto Perez et al.   Oncotarget

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis

(2014) Yan Mao et al.   PLoS One

FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast

(2013) Aseem Lal et al.   BREAST CANCER RESEARCH AND TREATMENT

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

(2013) A N Seo et al.   BRITISH JOURNAL OF CANCER

CD4+ follicular helper T cell infiltration predicts breast cancer survival

(2013) Chunyan Gu-Trantien et al.   JOURNAL OF CLINICAL INVESTIGATION

Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1

(2013) Manisha Singh et al.   Cancer Medicine

Prognostic impact of FOXP3 expression in triple-negative breast cancer

(2012) Soohyeon Lee et al.   ACTA ONCOLOGICA

Impairment of CD4+cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma

(2012) Junliang Fu et al.   HEPATOLOGY

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

(2012) Foluso O. Ademuyiwa et al.   PLoS One

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

(2011) Sahar M.A. Mahmoud et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers

(2011) Yao-Tseng Chen et al.   PLoS One

Leukocyte composition of human breast cancer

(2011) B. Ruffell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer-testis antigen expression in triple-negative breast cancer

(2010) G. Curigliano et al.   ANNALS OF ONCOLOGY

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules

(2010) Andrew E Teschendorff et al.   BMC CANCER

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

(2009) E.A. Rakha et al.   EUROPEAN JOURNAL OF CANCER

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

(2009) Carsten Denkert et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer

(2009) Aye Aye Thike et al.   MODERN PATHOLOGY

The anticancer immune response: indispensable for therapeutic success?

(2008) Laurence Zitvogel et al.   JOURNAL OF CLINICAL INVESTIGATION